Cancer Letters
Volume 241, Issue 1 , Pages 13-22 , 8 September 2006

Translesion DNA replication proteins as molecular targets for cancer prevention

  • Nicholas B. Watson

      Affiliations

    • Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA
    • Nicholas B. Watson and Suparna Mukhopadhyay contributed equally to this work.
    • ,
  • Suparna Mukhopadhyay

      Affiliations

    • Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA
    • Nicholas B. Watson and Suparna Mukhopadhyay contributed equally to this work.
    • ,
  • W. Glenn McGregor

      Affiliations

    • Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, USA
    • Center for Genetics and Molecular Medicine, University of Louisville, Louisville, KY, USA
    • Molecular Targets Program, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA
    • Corresponding Author InformationCorresponding author. Address: Department of Pharmacology and Toxicology, University of Louisville, 221A Baxter 1 Biomedical Research, 570 S. Preston Street, Louisville, KY 40202, USA. Tel.: +1 502 852 2564; fax: +1 502 852 2492.

Received 15 September 2005 ,Revised 10 October 2005 ,Accepted 13 October 2005.

References 

  1. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol. Carcinog. 1993;7:139–146
  2. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell. 1996;87:159–170
  3. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, et al. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001;15:50–65
  4. Hahn WC, Weinberg RA. Rules for making human tumor cells. N. Engl. J. Med. 2002;347:1593–1603
  5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  6. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature. 1991;351:453–456
  7. McGregor WG, Chen RH, Lukash L, Maher VM, McCormick JJ. Cell cycle-dependent strand bias for UV-induced mutations in the transcribed strand of excision repair-proficient human fibroblasts but not in repair-deficient cells. Mol. Cell Biol. 1991;11:1927–1934
  8. Friedberg EC, Wagner R, Radman M. Specialized DNA polymerases, cellular survival, and the genesis of mutations. Science. 2002;296:1627–1630
  9. Goodman MF. Error-prone repair DNA polymerases in prokaryotes and eukaryotes. Annu. Rev. Biochem. 2002;71:17–50
  10. Prakash S, Prakash L. Translesion DNA synthesis in eukaryotes: a one- or two-polymerase affair. Genes Dev. 2002;16:1872–1883
  11. Johnson RE, Kondratick CM, Prakash S, Prakash L. hRAD30 mutations in the variant form of xeroderma pigmentosum. Science. 1999;285:263–265
  12. Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 1999;399:700–704
  13. Tung BS, McGregor WG, Wang YC, Maher VM, McCormick JJ. Comparison of the rate of excision of major UV photoproducts in the strands of the human HPRT gene of normal and xeroderma pigmentosum variant cells. Mutat. Res. 1996;362:65–74
  14. Wang YC, Maher VM, Mitchell DL, McCormick JJ. Evidence from mutation spectra that the UV hypermutability of xeroderma pigmentosum variant cells reflects abnormal, error-prone replication on a template containing photoproducts. Mol. Cell Biol. 1993;13:4276–4283
  15. McGregor WG, Wei D, Maher VM, McCormick JJ. Abnormal, error-prone bypass of photoproducts by xeroderma pigmentosum variant cell extracts results in extreme strand bias for the kinds of mutations induced by UV light. Mol. Cell Biol. 1999;19:147–154
  16. Maher VM, Ouellette LM, Curren RD, McCormick JJ. Frequency of ultraviolet light-induced mutations is higher in xeroderma pigmentosum variant cells than in normal human cells. Nature. 1976;261:593–595
  17. Ohmori H, Friedberg EC, Fuchs RP, Goodman MF, Hanaoka F, Hinkle D, et al. The Y-family of DNA polymerases. Mol. Cell. 2001;8:7–8
  18. Johnson RE, Prakash S, Prakash L. Efficient bypass of a thymine—thymine dimer by yeast DNA polymerase, Poleta. Science. 1999;283:1001–1004
  19. Matsuda T, Bebenek K, Masutani C, Hanaoka F, Kunkel TA. Low fidelity DNA synthesis by human DNA polymerase-eta. Nature. 2000;404:1011–1013
  20. Yuan F, Zhang Y, Rajpal DK, Wu X, Guo D, Wang M, et al. Specificity of DNA lesion bypass by the yeast DNA polymerase eta. J. Biol. Chem. 2000;275:8233–8239
  21. McDonald JP, Rapic-Otrin V, Epstein JA, Broughton BC, Wang X, Lehmann AR, et al. Novel human and mouse homologs of saccharomyces cerevisiae DNA polymerase eta. Genomics. 1999;60:20–30
  22. Tissier A, McDonald JP, Frank EG, Woodgate R. poliota, a remarkably error-prone human DNA polymerase. Genes Dev. 2000;14:1642–1650
  23. Zhang Y, Yuan F, Wu X, Taylor JS, Wang Z. Response of human DNA polymerase iota to DNA lesions. Nucleic Acids Res. 2001;29:928–935
  24. Tissier A, Frank EG, McDonald JP, Iwai S, Hanaoka F, Woodgate R. Misinsertion and bypass of thymine–thymine dimers by human DNA polymerase iota. Eur. Mol. Boil. Org. J. 2000;19:5259–5266
  25. Ahrendt SA, Chow JT, Yang SC, Wu L, Zhang MJ, Jen J, et al. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer. Cancer Res. 2000;60:3155–3159
  26. Gibbs PE, McGregor WG, Maher VM, Nisson P, Lawrence CW. A human homolog of the saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc. Natl Acad. Sci. USA. 1998;95:6876–6880
  27. Gerlach VL, Aravind L, Gotway G, Schultz RA, Koonin EV, Friedberg EC. Human and mouse homologs of escherichia coli dinB (DNA polymerase IV), members of the UmuC/DinB superfamily. Proc. Natl Acad. Sci. USA. 1999;96:11922–11927
  28. Ohashi E, Bebenek K, Matsuda T, Feaver WJ, Gerlach VL, Friedberg EC. Fidelity and processivity of DNA synthesis by DNA polymerase kappa, the product of the human DINB1 gene. J. Biol. Chem. 2000;275:39678–39684
  29. Wang J, Kawamura K, Tada Y, Ohmori H, Kimura H, Sakiyama S, et al. DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res. 2001;61:5366–5369
  30. Ohashi E, Ogi T, Kusumoto R, Iwai S, Masutani C, Hanaoka F, et al. Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. Genes Dev. 2000;14:1589–1594
  31. Suzuki N, Ohashi E, Kolbanovskiy A, Geacintov NE, Grollman AP, Ohmori H, et al. Translesion synthesis by human DNA polymerase kappa on a DNA template containing a single stereoisomer of dG-(+)- or dG-(−)-anti-N(2)-BPDE (7,8-dihydroxy-anti-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene). Biochemistry. 2002;41:6100–6106
  32. Wagner J, Fujii S, Gruz P, Nohmi T, Fuchs RP. The beta clamp targets DNA polymerase IV to DNA and strongly increases its processivity. Eur. Mol. Biol. Org. Rep. 2000;1:484–488
  33. Washington MT, Johnson RE, Prakash L, Prakash S. Human DINB1-encoded DNA polymerase kappa is a promiscuous extender of mispaired primer termini. Proc. Natl Acad. Sci. USA. 2002;99:1910–1914
  34. Haracska L, Prakash L, Prakash S. Role of human DNA polymerase kappa as an extender in translesion synthesis. Proc. Natl Acad. Sci. USA. 2002;99:16000–16005
  35. Haracska L, Prakash S, Prakash L. Yeast DNA polymerase zeta is an efficient extender of primer ends opposite from 7,8-dihydro-8-oxoguanine and O6-methylguanine. Mol. Cell Biol. 2003;23:1453–1459
  36. Okada T, Sonoda E, Yamashita YM, Koyoshi S, Tateishi S, Yamaizumi M, et al. Involvement of vertebrate polkappa in Rad18-independent postreplication repair of UV damage. J. Biol. Chem. 2002;277:48690–48695
  37. Burgers PM, Koonin EV, Bruford E, Blanco L, Burtis KC, Christman MF, et al. Eukaryotic DNA polymerases: proposal for a revised nomenclature. J. Biol. Chem. 2001;276:43487–43490
  38. Lin W, Xin H, Zhang Y, Wu X, Yuan F, Wang Z. The human REV1 gene codes for a DNA template-dependent dCMP transferase. Nucleic Acids Res. 1999;27:4468–4475
  39. Huyton T, Bates PA, Zhang X, Sternberg MJ, Freemont PS. The BRCA1 C-terminal domain: structure and function. Mutat. Res. 2000;460:319–332
  40. Ross AL, Simpson LJ, Sale JE. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res. 2005;33:1280–1289
  41. Jansen JG, Tsaalbi-Shtylik A, Langerak P, Calleja F, Meijers CM, Jacobs H, et al. The BRCT domain of mammalian rev1 is involved in regulating DNA translesion synthesis. Nucleic Acids Res. 2005;33:356–365
  42. Lawrence CW. Cellular roles of DNA polymerase zeta and rev1 protein. DNA Repair (Amst). 2002;1:425–435
  43. Nelson JR, Gibbs PE, Nowicka AM, Hinkle DC, Lawrence CW. Evidence for a second function for Saccharomyces cerevisiae rev1p. Mol. Microbiol. 2000;37:549–554
  44. Zhang Y, Wu X, Rechkoblit O, Geacintov NE, Taylor JS, Wang Z. Response of human rev1 to different DNA damage: preferential dCMP insertion opposite the lesion. Nucleic Acids Res. 2002;30:1630–1638
  45. Gibbs PE, Wang XD, Li Z, McManus TP, McGregor WG, Lawrence CW, et al. The function of the human homolog of Saccharomyces cerevisiae REV1 is required for mutagenesis induced by UV light. Proc. Natl Acad. Sci. USA. 2000;97:4186–4191
  46. Clark DR, Zacharias W, Panaitescu L, McGregor WG. Ribozyme-mediated rev1 inhibition reduces the frequency of UV-induced mutations in the human HPRT gene. Nucleic Acids Res. 2003;31:4981–4988
  47. Mukhopadhyay S, Clark DR, Watson NB, Zacharias W, McGregor WG. REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo[a]pyrenediolepoxide. Nucleic Acids Res. 2004;32:5820–5826
  48. Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM. Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J. Biol. Chem. 2001;276:35644–35651
  49. Guo C, Fischhaber PL, Luk-Paszyc MJ, Masuda Y, Zhou J, Kamiya K. Mouse Rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. Eur. Mol. Boil. Org. J. 2003;22:6621–6630
  50. Lin W, Wu X, Wang Z. A full-length cDNA of hREV3 is predicted to encode DNA polymerase zeta for damage-induced mutagenesis in humans. Mutat. Res. 1999;433:89–98
  51. Braithwaite DK, Ito J. Compilation, alignment, and phylogenetic relationships of DNA polymerases. Nucleic Acids Res. 1993;21:787–802
  52. Ito J, Braithwaite DK. Compilation and alignment of DNA polymerase sequences. Nucleic Acids Res. 1991;19:4045–4057
  53. Li Z, Zhang H, McManus TP, McCormick JJ, Lawrence CW, Maher VM. hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts. Mutat. Res. 2002;510:71–80
  54. Zan H, Komori A, Li Z, Cerutti A, Schaffer A, Flajnik MF, et al. The translesion DNA polymerase zeta plays a major role in Ig and bcl-6 somatic hypermutation. Immunity. 2001;14:643–653
  55. Van Sloun PP, Romeijn RJ, Eeken JC. Molecular cloning, expression and chromosomal localisation of the mouse Rev3l gene, encoding the catalytic subunit of polymerase zeta. Mutat. Res. 1999;433:109–116
  56. Wittschieben J, Shivji MK, Lalani E, Jacobs MA, Marini F, Gearhart PJ, et al. Disruption of the developmentally regulated rev3l gene causes embryonic lethality. Curr. Biol. 2000;10:1217–1220
  57. Bemark M, Khamlichi AA, Davies SL, Neuberger MS. Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr. Biol. 2000;10:1213–1216
  58. Esposito G, Godindagger I, Klein U, Yaspo ML, Cumano A, Rajewsky K. Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality. Curr. Biol. 2000;10:1221–1224
  59. Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, McGregor WG. Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta. Mol. Cancer Res. 2003;1:836–847
  60. Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, et al. A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J. Biol. Chem. 2000;275:4391–4397
  61. Lawrence CW, Gibbs PE, Murante RS, Wang XD, Li Z, McManus TP, et al. Roles of DNA polymerase zeta and rev1 protein in eukaryotic mutagenesis and translesion replication. Cold Spring Harb. Symp. Quant. Biol. 2000;65:61–69
  62. Guo C, Fischhaber PL, Luk-Paszyc MJ, Masuda Y, Zhou J, Kamiya K, et al. Mouse rev1 protein interacts with multiple DNA polymerases involved in translesion DNA synthesis. Eur. Mol. Boil. Org. J. 2003;22:6621–6630
  63. Skoufias DA, Andreassen PR, Lacroix FB, Wilson L, Margolis RL. Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints. Proc. Natl Acad. Sci. USA. 2001;98:4492–4497
  64. Xiao W, Chow BL, Broomfield S, Hanna M. The saccharomyces cerevisiae RAD6 group is composed of an error-prone and two error-free postreplication repair pathways. Genetics. 2000;155:1633–1641
  65. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature. 2002;419:135–141
  66. Friedberg EC, Lehmann AR, Fuchs RP. Trading places: how do DNA polymerases switch during translesion DNA synthesis?. Mol. Cell. 2005;18:499–505
  67. Okada T, Sonoda E, Yamashita YM, Koyoshi S, Tateishi S, Yamaizumi M, et al. Involvement of vertebrate polkappa in Rad18-independent postreplication repair of UV damage. J. Biol. Chem. 2002;277:48690–48695
  68. Xin H, Lin W, Sumanasekera W, Zhang Y, Wu X, Wang Z. The human RAD18 gene product interacts with HHR6A and HHR6B. Nucleic Acids Res. 2000;28:2847–2854
  69. Tateishi S, Sakuraba Y, Masuyama S, Inoue H, Yamaizumi M. Dysfunction of human Rad18 results in defective postreplication repair and hypersensitivity to multiple mutagens. Proc. Natl Acad. Sci. USA. 2000;97:7927–7932
  70. Yamashita YM, Okada T, Matsusaka T, Sonoda E, Zhao GY, Araki K, et al. RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells. Eur. Mol. Boil. Org. J. 2002;21:5558–5566
  71. Tateishi S, Niwa H, Miyazaki J, Fujimoto S, Inoue H, Yamaizumi M. Enhanced genomic instability and defective postreplication repair in RAD18 knockout mouse embryonic stem cells. Mol. Cell Biol. 2003;23:474–481
  72. Lawrence CW, Christensen R. UV mutagenesis in radiation-sensitive strains of yeast. Genetics. 1976;82:207–232
  73. Prakash L. Characterization of postreplication repair in saccharomyces cerevisiae and effects of rad6, rad18, rev3 and rad52 mutations. Mol. Gen. Genet. 1981;184:471–478
  74. Fabre F, Magana-Schwencke N, Chanet R. Isolation of the RAD18 gene of Saccharomyces cerevisiae and construction of rad18 deletion mutants. Mol. Gen. Genet. 1989;215:425–430
  75. Ross AL, Simpson LJ, Sale JE. Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1. Nucleic Acids Res. 2005;33:1280–1289

PII: S0304-3835(05)00934-1

doi: 10.1016/j.canlet.2005.10.013

Cancer Letters
Volume 241, Issue 1 , Pages 13-22 , 8 September 2006

Article Tools

* Image Usage & Resolution